New heart valve implant tested for patients too risky for open surgery
NCT ID NCT05847751
Summary
This study is testing the ACURATE Neo2, a new type of artificial heart valve, in patients from the Middle East who have severe, symptomatic aortic stenosis. It involves 51 patients who are at intermediate or high risk for open-heart surgery and are getting the valve implanted via a catheter in their leg. The main goal is to check how safe the procedure is and how well the new valve works 30 days after implantation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain shams Specialized hospital
Cairo, Egypt
-
American University of Beirut
Beirut, Lebanon
-
Badr hospital
Cairo, Egypt
-
King Fahad Armed Forces Hospital
Jeddah, Saudi Arabia
-
King Fahad National Guard Hospital
Riyadh, Saudi Arabia
-
Magdy Yacoub heart center
Aswān, Egypt
-
National Guard Hospital - King Abdulaziz Medical City
Riyadh, Saudi Arabia
Conditions
Explore the condition pages connected to this study.